the impact of the treatment adherence promotion program on academic performance and quality of life of adolescents with cystic fibrosis
Not Applicable
Not yet recruiting
- Conditions
- Cystic fibrosis disease.Cystic fibrosis
- Registration Number
- IRCT20240718062462N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Suffering from cystic fibrosis
Not suffering from learning and cognitive diseases
Adolescents aged 12-16 years
Be busy studying
Declare the adolescent's consent and parents' consent to participate in the study
Not suffering from other debilitating disorders
Exclusion Criteria
In case of lack of satisfaction at any stage of the research, the participants can be excluded from the study
n case of not participating in 3 or more sessions in the orientation classes, the participant will be excluded from the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link treatment adherence to improved academic performance in cystic fibrosis adolescents?
How does the adherence promotion program compare to standard care in managing cystic fibrosis-related quality of life issues?
Are there specific biomarkers that correlate with better treatment adherence outcomes in cystic fibrosis patients?
What are the potential adverse events associated with adherence interventions in cystic fibrosis adolescents and how are they managed?
What combination therapies or compounds are being explored alongside adherence programs for cystic fibrosis treatment?